Lovelace Biomedical performs biomedical research to advance new therapies, understand the risk of drugs or toxicants, and characterize disease. This is performed at a single preclinical research site in Albuquerque, New Mexico. The laboratory specializes in GLP Toxicology, with a niche in respiratory, infectious disease, central nervous system, and gene therapy.
Preclinical research, preclinical study, or preclinical development, is conducted before clinical trials to ensure the safety and feasibility of a product on humans. Preclinical research product types and drug-related data is sourced and compiled carefully to advance drugs for humankind.
Preclinical research studies follow a stringent set of regulations found in 21 CFR Part 58.1 Good Laboratory Practice for Nonclinical Laboratory Studies which delves into basic requirements for the following:
- Study Conduct
- Written Protocols
- Operating Procedures
- Study Reports
- FDA-Regulated Product Safety
In Vivo Studies
In vivo studies address the limitations of in vitro studies and provide an overview of the effects a drug will have on the entire body, as opposed to isolated cells. These studies allow for a better understanding and visualization of predicted safety, toxicity, and efficacy, and allow researchers to predict the impact of the drug on human diseases. Unlike in vitro studies, in vivo is conducted on human or animal subjects.
Lovelace Biomedical, Leaders of the Industry
Located in Albuquerque, New Mexico, Lovelace Biomedical is equipped with experienced and knowledgeable scientists and researchers that are ready to handle a variety of preclinical programs. We’re trusted for our preclinical research and get results for our clients through extensive knowledge of our subjects. Our expansive 300,000 sq.ft. lab allows us the space necessary to properly research and obtain results in all our preclinical trials.
To inquire about partnering with Lovelace Biomedical, or to learn more about the work we do, please contact us online.